Dermatology NewsOlder psoriasis patients experience more adverse eventsApril 29, 2015PsoriasisPsoriatic Arthritis
Dermatology NewsNew psoriatic arthritis screening tool passes initial validationApril 17, 2015Psoriatic ArthritisPsoriasis
Dermatology NewsPsoriatic arthritis associated with heavy drinkingApril 17, 2015Psoriatic ArthritisPsoriasis
Dermatology NewsApremilast meets psoriasis endpoints at week 32April 12, 2015PsoriasisPsoriatic Arthritis
Dermatology NewsIxekizumab met psoriasis endpoints by week 12, with durable response at 60 weeksApril 9, 2015PsoriasisPsoriatic Arthritis
Dermatology NewsTraditional risk factors raise cardiovascular risk in PsAApril 2, 2015Psoriatic ArthritisPsoriasis
Dermatology NewsNo increased risk of lung disease with methotrexateApril 2, 2015Psoriatic ArthritisPsoriasis
Dermatology NewsMethotrexate and biologics linked to higher zoster risk in psoriasisMarch 22, 2015PsoriasisPsoriatic Arthritis
Dermatology NewsSecukinumab beat ustekinumab for psoriasis, with difference by week fourMarch 21, 2015PsoriasisPsoriatic Arthritis
Dermatology NewsBrodalumab achieved primary endpoints for moderate to severe psoriasis at 52 weeksMarch 21, 2015PsoriasisPsoriatic Arthritis
Dermatology NewsHalting biologics before surgery tied to flares in psoriasis, psoriatic arthritisMarch 13, 2015Psoriatic ArthritisPsoriasis
Dermatology NewsInterleukin-23 inhibition with tildrakizumab achieves significant psoriasis improvementsMarch 9, 2015PsoriasisPsoriatic Arthritis
Dermatology NewsVIDEO: Secukinumab ‘exciting’ new agent for psoriasisMarch 3, 2015PsoriasisPsoriatic Arthritis
